deltatrials
Unknown PHASE3 NCT00214656

Salvage Use of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Salvage Use of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial

Sponsor: Austin Health

Conditions Blood Coagulation Disorders Coronary Artery Disease Heart Valve Diseases Myocardial Ischemia
Interventions Recombinant Activated Factor VII
Updated 4 times since 2017 Last updated: Sep 14, 2005 Started: Jun 30, 2005 Completion: Jun 30, 2008

This PHASE3 trial investigates Blood Coagulation Disorders and Coronary Artery Disease and is currently ongoing. Austin Health leads this study, which shows 4 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jan 2017 — Jan 2021 [monthly]

    Unknown Status PHASE3

    First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Austin Health
Data source: Austin Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Melbourne, Australia